title: [New study findings in cardiology. The best is the enemy of the good].
authors.affiliation: DRK-Krankenhaus Westerwald, Hachenburg. pdrstiefel@aol.com
authors.forename: Peter
authors.initials: P
authors.lastname: Stiefelhagen
mesh_terms: D015906:Angioplasty, Balloon, Coronary / Q000639:trends; D057912:Angiotensin II Type 2 Receptor Blockers / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000188:drug therapy; D002309:Cardiology / Q000639:trends*; D003327:Coronary Disease / Q000188:drug therapy / Q000601:surgery; D054855:Drug-Eluting Stents; D006331:Heart Diseases / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D006801:Humans; D009025:Morpholines / Q000627:therapeutic use; D009203:Myocardial Infarction / Q000188:drug therapy; D000069552:Rivaroxaban; D013876:Thiophenes / Q000627:therapeutic use; D013927:Thrombosis / Q000188:drug therapy; D014812:Vitamin K / Q000037:antagonists & inhibitors
chemical_list: D057912:Angiotensin II Type 2 Receptor Blockers; D000925:Anticoagulants; D009025:Morpholines; D013876:Thiophenes; D014812:Vitamin K; D000069552:Rivaroxaban